National Research, operating as NRC Health, reported a net profit of $1.8 million, or 8 cents per share, for the final quarter of the year. This represents a steep decline from the $6.56 million, or 28 cents per share, recorded during the same period a year earlier. Even when adjusting for certain one-time items, the company’s earnings of 16 cents per share failed to shore up investor confidence.

Revenue and Market Reaction

The earnings miss coincided with a contraction in the company's top line. Revenue for the quarter slipped to $35.2 million, down from $36.9 million in the prior-year period. This financial retreat triggered a massive sell-off, erasing the stock's recent gains and marking a stark reversal for a security that had been up 4.9% over the past twelve months.

The 22% drop on Tuesday represents the company's most significant percentage decrease since it began trading. While the broader healthcare services sector has faced various headwinds, the scale of the retreat highlights specific investor concerns regarding the firm's immediate growth trajectory and operational efficiency following the disappointing year-end results.